SCHEMBL4902640

SCHEMBL4902640

CCN(c1nc2ccccc2s1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
ALDH1A1 P00352 5/20 0.46
TSHR P16473 2/20 0.45
ALOX15 P16050 1/20 0.45
GAA P10253 2/20 0.43
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
MAPT P10636 5/20 0.40
KDM4E B2RXH2 1/20 0.40
PRNP P04156 1/20 0.40
KAT8 Q9H7Z6 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906504 0.89 LMNA (0.48) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4905942 0.85 DYRK1A (0.41) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4905953 0.82 ALDH1A1 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4895889 0.79 NPC1 (0.47) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4906070 0.78 RAB9A (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4905784 0.76 LMNA (0.47) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4908510 0.76 ALDH1A1 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4902624 0.75 SMN1; SMN2 (0.53) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL4897647 0.74 LMNA (0.41) MEN1KMT2AALDH1A1ALOX15LMNA
SCHEMBL4906126 0.74 MEN1 (0.41) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MEN1 4859/4885KMT2A 3602/4885NPC1 50/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885NPC1 59/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885NPC1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.